Ata uhi

Diabetes and MRSA Infections: A comparative analysis in an Indian tertiary healthcare setting

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	M. Sagiraju (Author), R. Prasad (Author), A. Gopi (Author)
Hōputu:	Pukapuka
I whakaputaina:	Elsevier, 2024-09-01T00:00:00Z.
Ngā marau:	article
Urunga tuihono:	Connect to this object online.
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

Comparative and molecular analysis of MRSA isolates from infection sites and carrier colonization sites
mā: Khaled R. Alkharsah, me ētahi atu.
I whakaputaina: (2018)

Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections
mā: Matsumoto K, me ētahi atu.
I whakaputaina: (2016)

Comparative Effectiveness Study of Home-Based Interventions to Prevent CA-MRSA Infection Recurrence
mā: Jonathan N. Tobin, me ētahi atu.
I whakaputaina: (2021)

Preventing healthcare-associated MRSA bacteremia: getting to the root of the problem
mā: Michael A. Borg, me ētahi atu.
I whakaputaina: (2023)

Comparative Analysis of Healthcare-associated Bloodstream Infections & CLABSI Surveillance in A Singaporean tertiary Hospital
mā: Shalvi Arora, me ētahi atu.
I whakaputaina: (2024)

Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in Southwestern Nigeria
mā: Adisa R, me ētahi atu.
I whakaputaina: (2011)

Cost-Utility Analysis of Dapagliflozin Compared to Sulfonylureas for Type 2 Diabetes as Second-Line Treatment in Indian Healthcare Payer’s Perspective
mā: Bagepally BS, me ētahi atu.
I whakaputaina: (2021)

Active surveillance and contact precautions for preventing MRSA healthcare-associated infections during the COVID-19 pandemic
mā: Brian McCauley, me ētahi atu.
I whakaputaina: (2023)

MRSA-colonized persons' and healthcare personnel's experiences of patient-professional interactions in and responsibilities for infection prevention in Sweden
mā: Maria Lindberg, me ētahi atu.
I whakaputaina: (2014)

Implementation of MRSA Nasal Swabs as an Antimicrobial Stewardship Intervention to Decrease Anti-MRSA Therapy in COVID-19 Infection
mā: Alaina DeKerlegand, me ētahi atu.
I whakaputaina: (2023)

Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus (MRSA) Isolated from Diabetic Foot Infection
mā: Pegah Kananizadeh, me ētahi atu.
I whakaputaina: (2019)

Preventing MRSA Infections in Sports: Effective Strategies and Approaches
mā: Karolina Pawłuszkiewicz, me ētahi atu.
I whakaputaina: (2024)

Suppurative Infections in Hospitalized Patients - An Ongoing MRSA Threat
mā: Sadaf Razzak, me ētahi atu.
I whakaputaina: (2020)

Assessment of cost of illness for diabetic patients in South Indian tertiary care hospital
mā: Leelavathi D Acharya, me ētahi atu.
I whakaputaina: (2016)

MRSA Infection in Patients Hospitalized at Sanglah Hospital: A Case Series
mā: A.A. Ayu Yuli Gayatri, me ētahi atu.
I whakaputaina: (2015)

In vivo screening and evaluation of four herbs against MRSA infections
mā: Najma Arshad, me ētahi atu.
I whakaputaina: (2017)

Evaluation of the statutory surveillance system for invasive MRSA infections in Germany, 2016-2017
mā: Viktoria Schönfeld, me ētahi atu.
I whakaputaina: (2018)

Infant with MRSA necrotizing fasciitis
mā: Panglao Rajan M, me ētahi atu.
I whakaputaina: (2014)

Higher incidence of perineal community acquired MRSA infections among toddlers
mā: Blumenthal Robert M, me ētahi atu.
I whakaputaina: (2011)

Nasal Decolonisation of MRSA
mā: Peter Mantle
I whakaputaina: (2019)

Phage-antibiotic combinations in various treatment modalities to manage MRSA infections
mā: Archana Loganathan, me ētahi atu.
I whakaputaina: (2024)

Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
mā: Oriana Simonetti, me ētahi atu.
I whakaputaina: (2021)

MRSA and Skin Infections in Psoriatic Patients: Therapeutic Options and New Perspectives
mā: Giulio Rizzetto, me ētahi atu.
I whakaputaina: (2022)

Salphage: Salvage Bacteriophage Therapy for Recalcitrant MRSA Prosthetic Joint Infection
mā: James B. Doub, me ētahi atu.
I whakaputaina: (2022)

Salvage Bacteriophage Therapy for a Chronic MRSA Prosthetic Joint Infection
mā: James B. Doub, me ētahi atu.
I whakaputaina: (2020)

Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections
mā: Cui Longzhu, me ētahi atu.
I whakaputaina: (2007)

When is vancomycin prophylaxis necessary? Risk factors for MRSA surgical site infection
mā: Cynthia T. Nguyen, me ētahi atu.
I whakaputaina: (2024)

Molecular epidemiology of clinical and carrier strains of methicillin resistant <it>Staphylococcus aureus </it>(MRSA) in the hospital settings of north India
mā: Dar Mohammad J, me ētahi atu.
I whakaputaina: (2006)

A 4-year outbreak of MRSA ST72-MRSA-IV spa type t1597 in a surgical high dependency unit in Ireland linked to repeated healthcare worker recolonisation
mā: Deirdre Brady, me ētahi atu.
I whakaputaina: (2025)

The role of pharmacoeconomics in current Indian healthcare system
mā: Akram Ahmad, me ētahi atu.
I whakaputaina: (2013)

Patterns and Determinants of Primary Tooth Extraction in Children: A Study in an Indian Tertiary Care Dental Setting
mā: Shamsher Singh, me ētahi atu.
I whakaputaina: (2024)

A successful cost effective Meticillin Resistant Staphylococcus aureus (MRSA) eradication protocol implemented at a Tertiary Care Unit
mā: T.R. Chinniah, me ētahi atu.
I whakaputaina: (2020)

Impact of Stewardship Pharmacist Driven MRSA Nasal Surveillance and De-escalation of Anti-MRSA Therapy
mā: Jessica Dillon, me ētahi atu.
I whakaputaina: (2024)

Nasal conveyance of Methicillin-resistant Staphylococcus aureus (MRSA) strains among dental professionals with varying levels of clinical exposure: A comparative study
mā: Nandita Subba Rao, me ētahi atu.
I whakaputaina: (2020)

S. aureus Surveillance and Decolonization Associated with Decreased MRSA, but not MSSA, Infections in the Neonatal ICU
mā: Patrick Reich, me ētahi atu.
I whakaputaina: (2024)

Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections
mā: Lukáš Vacek, me ētahi atu.
I whakaputaina: (2020)

NEW CEPHALOSPORIN AS AN ALTERNATIVE FOR TREATMENT OF INFECTIONS BY METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA)
mā: Bruna Gerardon Batista
I whakaputaina: (2015)

Community-acquired and healthcare-associated Staphylococcus aureus infections in a pediatric hospital in southern Brazil over 8 years: how common is MRSA?
mā: Derrick Alexandre Fassbind, me ētahi atu.
I whakaputaina: (2023)

Characterisation of antibiotic resistance, virulence, clonality and mortality in MRSA and MSSA bloodstream infections at a tertiary-level hospital in Hungary: a 6-year retrospective study
mā: Andrea Horváth, me ētahi atu.
I whakaputaina: (2020)

<i>Staphylococcus aureus</i> and CA-MRSA Carriage among Brazilian Indians Living in Peri-Urban Areas and Remote Communities
mā: Lígia Maria Abraão, me ētahi atu.
I whakaputaina: (2023)